Tumor-infiltrating pDCs are reported to produce immunosuppressive and carcinogenic effects; however, due to their ability to secrete INF-I and TNF-α, pDCs are potential therapeutic targets for combating cancer [71,72]. The gene discussed is TNF; the disease is neoplasm.